Our Pricing

Wegovy Side Effects UK: What to Expect & How to Get Your Online Prescription

Published on: June 03, 2026

Searching for reliable information on wegovy side effects uk online prescription services? At Cured Pharmacy, our UK-registered clinical team provides transparent guidance on what to expect from semaglutide treatment, with online prescriptions issued in under 3 minutes and genuine Wegovy pens delivered discreetly from £79.00. Understanding potential side effects before starting treatment helps you make informed decisions about your weight loss journey.

Common Wegovy Side Effects: What Clinical Trials Show

Wegovy contains semaglutide, a GLP-1 receptor agonist that slows gastric emptying and reduces appetite [1]. In the landmark STEP 1 trial involving 1,961 adults, the most frequently reported side effects were gastrointestinal in nature, affecting approximately 74% of participants at some point during the 68-week study period [1].

Nausea was the most common side effect, reported by 44% of participants taking semaglutide compared to 17% on placebo [1]. Other frequently reported effects included diarrhoea (31%), vomiting (24%), constipation (24%), and abdominal pain (20%) [1]. These symptoms typically emerged during dose escalation phases and diminished over time as the body adapted to treatment.

Most gastrointestinal side effects were classified as mild to moderate in severity, with only 4.5% of participants discontinuing Wegovy due to adverse events in clinical trials [1]. Our clinical team at Cured Pharmacy monitors patients throughout their treatment journey, providing practical guidance on managing these effects whilst ensuring therapeutic benefits are maintained.

Managing Wegovy Side Effects: Practical Strategies from UK Pharmacists

The graduated dosing schedule built into Wegovy's treatment protocol exists specifically to minimise side effects whilst your body adjusts to semaglutide. Starting at 0.25mg weekly and increasing gradually over 16-20 weeks allows your digestive system to adapt to slower gastric emptying [2].

To reduce nausea and gastrointestinal discomfort, our superintendent pharmacist Tarun Kumar recommends eating smaller, more frequent meals rather than three large portions daily. Avoiding high-fat, greasy foods during the initial weeks can significantly reduce digestive upset, as these foods take longer to process when gastric emptying is slowed.

Staying well-hydrated is essential, particularly if you experience vomiting or diarrhoea. Sipping water throughout the day rather than drinking large amounts at once can help prevent nausea. If side effects persist beyond the first few weeks at a given dose or become severe, contact your prescriber before your next injection — dose adjustments may be appropriate.

When to Seek Medical Advice

Whilst most Wegovy side effects resolve independently, certain symptoms require immediate medical attention. Severe abdominal pain that doesn't resolve, particularly if accompanied by nausea and vomiting, may indicate pancreatitis — a rare but serious side effect reported in less than 1% of clinical trial participants [1]. Similarly, symptoms of gallbladder disease including persistent pain in the upper right abdomen warrant urgent GP review.

Changes in vision, persistent severe headaches, or signs of thyroid nodules (a lump in the neck, difficulty swallowing) should be reported to your healthcare provider promptly. Our clinical team at Cured Pharmacy provides ongoing support throughout treatment, and you can contact us on (+44) 116 4646009 if you have concerns about any symptoms you're experiencing.

Wegovy Side Effects UK Online Prescription: How Our 3-Minute Service Works

Getting your Wegovy prescription online through Cured Pharmacy takes under 3 minutes and involves a thorough clinical assessment by UK-registered prescribers. Our medical questionnaire covers your weight history, previous weight loss attempts, current medications, and relevant medical conditions to ensure semaglutide is safe and appropriate for you.

Unlike high-street consultations, our transparent pricing model shows you the exact cost (£79.00 per pen) before you begin your assessment. There are no hidden fees, and our prices are the lowest guaranteed in the UK for genuine MHRA-licensed Wegovy. Once your prescriber approves treatment, your medication is dispensed from our GPhC-registered pharmacy (registration 9012511) and delivered in 100% discreet packaging.

Your initial prescription includes detailed guidance on injection technique, dose escalation schedules, and managing potential side effects. We provide ongoing clinical support throughout your treatment, with prescribers available to adjust your dose or provide additional advice as needed. This comprehensive approach ensures you're fully informed about what to expect from Wegovy before your first injection.

Who Can Get a Wegovy Prescription Online

Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or sleep apnoea [3]. Our prescribers assess your eligibility based on current MHRA and NICE guidance, ensuring treatment is both safe and clinically appropriate for your circumstances.

Certain medical conditions may preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Your online assessment captures these contraindications, and our clinical team will recommend alternative treatments if semaglutide isn't suitable for you.

Rare but Serious Wegovy Side Effects: What You Need to Know

Whilst the majority of Wegovy side effects are mild and transient, prescribers must inform patients of rare but serious risks identified in clinical trials and post-marketing surveillance. Acute pancreatitis occurred in 0.2% of semaglutide-treated patients versus 0.1% on placebo in the STEP trials [1]. Symptoms include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting.

Gallbladder disorders, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), were reported more frequently in patients taking semaglutide compared to placebo [1]. Rapid weight loss itself increases gallstone risk, making it difficult to separate medication effects from weight reduction effects. If you develop sustained pain in your upper right abdomen, particularly after eating fatty meals, contact your GP promptly.

Thyroid C-cell tumours were observed in rodent studies at exposures significantly higher than therapeutic human doses [3]. Whilst no causal relationship has been established in humans, Wegovy carries a contraindication for patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Our prescribers screen for these conditions during your online assessment.

Semaglutide Side Effects vs Other Weight Loss Treatments

Different weight loss medications work through distinct mechanisms, resulting in varying side effect profiles. Orlistat, a lipase inhibitor, causes predominantly gastrointestinal effects related to fat malabsorption — oily stools, faecal urgency, and flatulence — which differ substantially from semaglutide's nausea and reduced appetite effects.

Compared to liraglutide (marketed as Saxenda for weight loss), semaglutide demonstrates similar types of side effects but potentially lower rates due to its once-weekly dosing versus daily injections [2]. The STEP 8 trial directly compared semaglutide 2.4mg weekly against liraglutide 3.0mg daily, finding comparable safety profiles but greater weight loss with semaglutide (15.8% vs 6.4% average reduction) [4].

Tirzepatide-based treatments like Mounjaro, which activate both GIP and GLP-1 receptors, show similar gastrointestinal side effect patterns to semaglutide, though some patients report better tolerability with one medication over another. Individual response varies considerably, and our prescribers can recommend alternative treatments if you experience persistent side effects with your initial medication.

Choosing Between Injectable and Oral Weight Loss Treatments

Injectable GLP-1 receptor agonists like Wegovy produce greater average weight loss than oral medications, but the injection requirement and potential for nausea may not suit everyone. Oral semaglutide (marketed as Rybelsus for diabetes) offers an alternative route of administration, though it's not currently licensed for weight management in the UK at the higher doses used in Wegovy.

Your choice of treatment should balance efficacy expectations, side effect tolerance, lifestyle factors, and medical history. Our UK prescribers discuss these considerations during your online consultation, ensuring you receive the most appropriate medication for your individual circumstances. All prescription treatments dispensed by Cured Pharmacy are genuine UK-licensed products, never imported or counterfeit alternatives.

Long-Term Safety and Monitoring on Wegovy

The STEP clinical trial programme followed participants for up to 68 weeks, providing robust data on medium-term safety [1]. Post-marketing surveillance continues to monitor long-term outcomes as Wegovy use expands across the UK. Most patients who continue treatment beyond one year maintain their weight loss without developing new or worsening side effects, suggesting good long-term tolerability.

Regular monitoring during Wegovy treatment typically includes periodic weight and blood pressure checks, along with assessment for emerging side effects or complications. Patients with diabetes require glucose monitoring, as semaglutide can significantly reduce blood sugar levels, potentially necessitating adjustment of other diabetes medications to prevent hypoglycaemia.

At Cured Pharmacy, we facilitate ongoing care through our UK clinical team, who review your progress and can adjust prescriptions as needed. If you develop concerning symptoms or your weight loss plateaus, our prescribers can modify your treatment plan or recommend complementary interventions. Successful weight management combines medication with sustainable lifestyle changes, and our team provides guidance on nutrition and physical activity alongside pharmaceutical treatment.

Stopping Wegovy: What Happens When You Discontinue Treatment

Weight regain after stopping Wegovy is common, with the STEP 1 trial extension showing participants regained approximately two-thirds of lost weight within one year of discontinuation [1]. This reflects the chronic nature of obesity and the physiological mechanisms that defend against sustained weight loss, rather than a specific rebound effect of the medication itself.

If you need to stop Wegovy due to side effects, pregnancy, or other medical reasons, discuss this with your prescriber rather than discontinuing abruptly. Whilst there's no physical withdrawal syndrome, sudden cessation means losing the appetite-suppressing and metabolic benefits immediately. Your prescriber may recommend transitioning to an alternative weight management approach to help maintain your achieved weight loss.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., Dicker, D., & STEP 4 Investigators. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Medicines and Healthcare products Regulatory Agency. (2022). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., Wadden, T. A., Wizert, A., Garvey, W. T., & STEP 8 Investigators. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and side effects can differ between patients. If you experience severe or persistent side effects, contact your prescriber or GP immediately.